• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗原特异性启动在清除凋亡敏感T细胞以预防移植物抗宿主病中并非必需。

Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD Prophylaxis.

作者信息

Yarkoni Shai, Stein Jerry, Yaniv Isaac, Askenasy Nadir

机构信息

Cellect Biomed , Kfar Saba , Israel.

Bone Marrow Transplant Unit, Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel , Petah Tikva , Israel.

出版信息

Front Immunol. 2014 May 19;5:215. doi: 10.3389/fimmu.2014.00215. eCollection 2014.

DOI:10.3389/fimmu.2014.00215
PMID:24904571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4032906/
Abstract

Prophylactic approaches to graft versus host disease (GvHD) have employed both phenotypic reduction of T cells and selective elimination of host-primed donor T cells in vitro and in vivo. An additional approach to GvHD prophylaxis by functional depletion of apoptosis-sensitive donor T cells without host-specific sensitization ex vivo showed remarkable reduction in GHD incidence and severity. We address the role and significance of antigen-specific sensitization of donor T cells and discuss the mechanisms of functional T cell purging by apoptosis for GvHD prevention. Host-specific sensitization is dispensable because migration is antigen-independent and donor T cell sensitization is mediated by multiple and redundant mechanisms of presentation of major and minor histocompatibility complex and tissue antigens by donor and host antigen-presenting cells. Our data suggest that potential murine and human GvH effectors reside within subsets of preactivated T cells susceptible to negative regulation by apoptosis prior to encounter of and sensitization to specific antigens.

摘要

移植物抗宿主病(GvHD)的预防方法包括在体外和体内对T细胞进行表型减少以及选择性清除宿主致敏的供体T细胞。另一种通过在体外对凋亡敏感的供体T细胞进行功能耗竭来预防GvHD的方法,且无需宿主特异性致敏,结果显示GHD的发生率和严重程度显著降低。我们探讨了供体T细胞抗原特异性致敏的作用和意义,并讨论了通过凋亡进行功能性T细胞清除以预防GvHD的机制。宿主特异性致敏是不必要的,因为迁移不依赖抗原,且供体T细胞致敏是由供体和宿主抗原呈递细胞呈递主要和次要组织相容性复合体及组织抗原的多种冗余机制介导的。我们的数据表明,潜在的小鼠和人类移植物抗宿主效应细胞存在于预激活T细胞亚群中,这些亚群在遇到特定抗原并致敏之前易受凋亡的负调控。

相似文献

1
Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD Prophylaxis.抗原特异性启动在清除凋亡敏感T细胞以预防移植物抗宿主病中并非必需。
Front Immunol. 2014 May 19;5:215. doi: 10.3389/fimmu.2014.00215. eCollection 2014.
2
Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.调节性T细胞对CD8 + T细胞介导的移植物抗宿主反应的抑制作用需要它们在启动过程中存在。
Transplantation. 2009 Jul 27;88(2):188-97. doi: 10.1097/TP.0b013e3181ac14ce.
3
Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.供体淋巴细胞输注后的移植物抗白血病反应和移植物抗宿主反应由宿主型抗原呈递细胞启动,并在早期和长期嵌合体中由调节性T细胞调节。
Biol Blood Marrow Transplant. 2006 Apr;12(4):397-407. doi: 10.1016/j.bbmt.2005.11.519.
4
Pretransplant detection of human minor histocompatibility antigen-specific naive and memory interleukin-2-secreting T cells within class I major histocompatibility complex (MHC)-restricted CD8+ and class II MHC-restricted CD4+ T-cell subsets.在I类主要组织相容性复合体(MHC)限制的CD8 +和II类MHC限制的CD4 + T细胞亚群中,对人类次要组织相容性抗原特异性的初始和记忆性白细胞介素-2分泌T细胞进行移植前检测。
Blood. 1993 Jul 1;82(1):298-306.
5
Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation.在小鼠移植物抗宿主病中向 T 细胞呈递抗原的机制:交叉呈递和交叉呈递的出现。
Blood. 2011 Dec 8;118(24):6426-37. doi: 10.1182/blood-2011-06-358747. Epub 2011 Sep 30.
6
Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease.氯喹治疗会影响针对次要组织相容性抗原的T细胞致敏以及移植物抗宿主病。
Blood. 1995 Dec 1;86(11):4344-52.
7
Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.用αβT细胞受体单克隆抗体处理供体小鼠可诱导T细胞长期无反应性,并有效预防主要组织相容性复合体(MHC)匹配和MHC不匹配的供体骨髓移植小鼠受体中的致死性移植物抗宿主病。
Blood. 1996 Jun 15;87(12):5355-69.
8
A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo.通过体内选择性清除供体自然杀伤细胞,在进行主要组织相容性复合体匹配的骨髓移植后,移植物抗宿主病减少,而移植物抗白血病反应性未丧失。
Transplantation. 1992 Jul;54(1):104-12. doi: 10.1097/00007890-199207000-00019.
9
Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.选择性清除同种异体反应性供体T细胞可减轻移植物抗宿主病并增强T细胞重建。
Biol Blood Marrow Transplant. 2003 Dec;9(12):742-52. doi: 10.1016/j.bbmt.2003.09.007.
10
Depletion of naïve lymphocytes with fas ligand ex vivo prevents graft-versus-host disease without impairing T cell support of engraftment or graft-versus-tumor activity.体外耗竭幼稚淋巴细胞联合 FasL 可预防移植物抗宿主病而不损害 T 细胞支持植入或移植物抗肿瘤活性。
Biol Blood Marrow Transplant. 2013 Feb;19(2):185-95. doi: 10.1016/j.bbmt.2012.10.004. Epub 2012 Oct 16.

引用本文的文献

1
Donor Allospecific CD44 Central Memory T Cells Have Decreased Ability to Mediate Graft-vs.-Host Disease.供者同种异体 CD44 中央记忆 T 细胞介导移植物抗宿主病的能力降低。
Front Immunol. 2019 Apr 2;10:624. doi: 10.3389/fimmu.2019.00624. eCollection 2019.
2
Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective.造血嵌合体诱导耐受的机制:免疫观点。
Stem Cells Transl Med. 2017 Mar;6(3):700-712. doi: 10.1002/sctm.16-0358. Epub 2017 Jan 3.

本文引用的文献

1
Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts.通过凋亡进行的阴性选择可使原始和扩增的人脐带血移植物中的祖细胞增多。
Bone Marrow Transplant. 2014 Jul;49(7):942-9. doi: 10.1038/bmt.2014.79. Epub 2014 Apr 28.
2
Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts.通过 Fas 和 TNF 受体的凋亡信号转导可改善动员外周血移植物中的移植物抗宿主病。
Bone Marrow Transplant. 2014 May;49(5):640-8. doi: 10.1038/bmt.2014.12. Epub 2014 Feb 24.
3
Activation and crosstalk between TNF family receptors in umbilical cord blood cells is not responsible for loss of engraftment capacity following culture.
脐带血细胞中肿瘤坏死因子家族受体之间的激活和相互作用并非培养后植入能力丧失的原因。
Am J Stem Cells. 2013 Dec 22;2(3):155-64. eCollection 2013.
4
Resistance of hematopoietic progenitors to Fas-mediated apoptosis is actively sustained by NFκB with a characteristic transcriptional signature.造血祖细胞对Fas介导的细胞凋亡的抗性由具有特征性转录特征的NFκB积极维持。
Stem Cells Dev. 2014 Mar 15;23(6):676-86. doi: 10.1089/scd.2013.0270. Epub 2013 Dec 31.
5
Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis.使用临床级磁性CD45RA磁珠清除初始T细胞:预防移植物抗宿主病的新方法。
Bone Marrow Transplant. 2014 Jan;49(1):138-44. doi: 10.1038/bmt.2013.114. Epub 2013 Aug 12.
6
TNF-α has tropic rather than apoptotic activity in human hematopoietic progenitors: involvement of TNF receptor-1 and caspase-8.TNF-α 在人造血祖细胞中具有营养而非凋亡活性:涉及 TNF 受体-1 和胱天蛋白酶-8。
Stem Cells. 2013 Jan;31(1):156-66. doi: 10.1002/stem.1259.
7
Depletion of naïve lymphocytes with fas ligand ex vivo prevents graft-versus-host disease without impairing T cell support of engraftment or graft-versus-tumor activity.体外耗竭幼稚淋巴细胞联合 FasL 可预防移植物抗宿主病而不损害 T 细胞支持植入或移植物抗肿瘤活性。
Biol Blood Marrow Transplant. 2013 Feb;19(2):185-95. doi: 10.1016/j.bbmt.2012.10.004. Epub 2012 Oct 16.
8
Advances in graft-versus-host disease biology and therapy.移植物抗宿主病生物学和治疗的进展。
Nat Rev Immunol. 2012 May 11;12(6):443-58. doi: 10.1038/nri3212.
9
IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy.白细胞介素-2 靶向治疗改善移植物抗宿主病的严重程度:体外选择性耗竭宿主反应性 T 细胞和体内治疗。
Biol Blood Marrow Transplant. 2012 Apr;18(4):523-35. doi: 10.1016/j.bbmt.2011.11.016. Epub 2012 Jan 3.
10
Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantation.在接受体内T细胞去除而非T细胞补充的异基因外周血造血细胞移植的患者中,输注更高剂量的CD34+细胞与总生存率相关。
Hematol Oncol Stem Cell Ther. 2011;4(4):149-56. doi: 10.5144/1658-3876.2011.149.